EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical management of human herpesvirus-8-related illnesses in solid organ transplant recipients

Alessia Dalla Pria, Ines Ushiro-Lumb, Mark Bower

Journal of Infection · 2025-02 · 90 (2) · 106366

DOI: 10.1016/j.jinf.2024.106366 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Infection, 2025-02. Verfasst von Alessia Dalla Pria und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK; Centre for Immunology and Vaccinology, D…. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Transplant Recipients, Herpesviridae Infections, Sarcoma, Kaposi. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In solid organ transplant recipients (SOTRs), the oncogenic virus human herpesvirus-8 (HHV-8) also named Kaposi sarcoma herpesvirus (KSHV) causes four clinical diseases: Kaposi Sarcoma, Primary Effusion Lymphoma, Multicentric Castleman Disease (MCD), and KSHV inflammatory cytokine syndrome (KICS). This review outlines these clinical scenarios and discusses their management. Although HHV8-related disease in SOTR was first described more than three decades ago, there is a lack of data on treatment so much of the guidance is based on evidence in other immunodeficient patients, particularly people living with HIV. Whilst reduction of immunosuppression and switch from calcineurin inhibitors to mTOR inhibitors may be sufficient in early-stage post-transplant KS, systemic chemotherapy is necessary for advanced-stage KS and in KSHV-related lymphomas. For MCD and KICS, which usually follow primary HHV-8 infection, rituximab-based immunochemotherapy regimens are the cornerstone of treatment for these potentially lethal diseases. Although HHV-8 infection in SOTR is well recognized, it remains under-reported and greater awareness of the different clinical presentations of HHV-8 in this context is fundamental to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanTransplant RecipientsHerpesviridae InfectionsSarcoma, KaposiOrgan TransplantationHumansCastleman DiseaseLymphoma, Primary EffusionImmunocompromised Host

Stichwörter der Autor:innen

Graft-related infectionHHV8KSHVPost-transplant Kaposi SarcomaPrimary infectionSolid organ transplant

Autor:innen und Institutionen

  • Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK; Centre for Immunology and Vaccinology, Department of Infectious Diseases, Imperial College, London, UK. Electr…
  • Organ and Tissue Donation and Transplantation, NHS Blood and Transplant (NHSBT), London, UK. Electronic address: Ines.Ushiro-Lumb@nhsbt.nhs.uk.

Zitieren

APA

Dalla Pria, A., Ushiro-Lumb, I., & Bower, M. (2025). Clinical management of human herpesvirus-8-related illnesses in solid organ transplant recipients. Journal of Infection, 90(2), 106366. https://doi.org/10.1016/j.jinf.2024.106366

Vancouver

Dalla Pria A, Ushiro-Lumb I, Bower M. Clinical management of human herpesvirus-8-related illnesses in solid organ transplant recipients. Journal of Infection. 2025;90(2):106366. doi:10.1016/j.jinf.2024.106366

BibTeX
@article{DallaPria2025,
  author = {Dalla Pria, Alessia and Ushiro-Lumb, Ines and Bower, Mark},
  title = {Clinical management of human herpesvirus-8-related illnesses in solid organ transplant recipients},
  journal = {Journal of Infection},
  year = {2025},
  volume = {90},
  number = {2},
  pages = {106366},
  doi = {10.1016/j.jinf.2024.106366}
}
Kostenlos starten →